Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,562 JPY | +0.29% | +3.20% | -7.33% |
05-02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
05-01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.33% | 18.14B | |
+31.52% | 690B | |
+24.14% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.79% | 235B | |
+4.19% | 199B | |
-10.27% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 4503 Stock
- News Astellas Pharma Inc.
- Astellas Pharma Rejigs Top Management